This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


peer-reviewed publication

trusted source


The importance of a disturbed lipid metabolism in Charcot-Marie-Tooth disease

The importance of a disturbed lipid metabolism in Charcot-Marie-Tooth disease
Confocal image of a giant plasma membrane vesicle, part of the spectral analysis to detect the composition of ordered and disordered lipids in the membranes of patient Schwann cells. Credit: Dr. Tim Vangansewinkel

Charcot-Marie-Tooth (CMT) disease, a group of heritable disorders that affect the peripheral nerves, is marked by specific genetic changes. Research by the team of Prof. Ludo Van Den Bosch (VIB-KU Leuven) now reveals the effects of one such genetic cause.

They found that the duplication of the gene PMP22 causes problems in the cell membrane of Schwann cells that provide the insulating cover for nerves. The team has published the results of their study in the journal Brain.

Gene duplication in CMT1A

CMT disease is a group of inherited disorders that affect the peripheral nerves, leading to muscle weakness and sensory loss in the extremities. Among the various subtypes of CMT, CMT1A is the most common form, characterized by a duplication of the PMP22 gene. Despite being a well-known genetic abnormality associated with CMT1A, the precise mechanisms by which PMP22 duplication contributes to the disease have remained elusive until now.

The PMP22 gene codes for Peripheral Myelin Protein 22, a protein that is part of the myelin sheath—the protective cover—of peripheral nerves. That myelin sheath degrades in CMT1A. Because the PMP22 protein is produced by Schwann cells, that's where the lab of Prof. Ludo Van Den Bosch (VIB-KU Leuven Center for Brain & Disease Research) focused their attention. By investigating human cell cultures and animal models of CMT with the PMP22 duplication, the researchers could assess the impact of PMP22 duplication on developing Schwann cells.

The importance of a disturbed lipid metabolism in Charcot-Marie-Tooth disease
Perturbed lipid homeostasis during human CMT1A Schwann cell development. The figure was created with Credit: Alessio Silva, Dr. Robert Prior, Dr. Tim Vangansewinkel

Lipids and membranes

Starting from induced (iPSCs) differentiated into human Schwann cells and using advanced imaging techniques and molecular analyses, the researchers were able to elucidate the intricate pathways through which PMP22 duplication dysregulates and disrupts the normal functioning of Schwann cells.

Dr. Robert Prior, co-first author of the study (previously VIB-KU Leuven, now UKB Bonn, Germany), said, "One of our key findings was the identification of dysregulated lipids in the plasma membrane of developing human Schwann cells carrying the PMP22 duplication. This impairs the structural integrity and bending properties of the plasma membrane, compromising the ability of the Schwann cells to 'wrap' around the peripheral nerves, producing a lipid-rich cover called myelin.

"This electrically insulates the nerves and Schwann cells also provide metabolic support. The dysregulation of lipids in the plasma membrane finally allows us to understand why the communication between CMT1A patient Schwann cells and peripheral nerves breaks down, even before the onset of myelination."

Moreover, the researchers discovered that targeting the dysregulated lipid pathways in Schwann cells could potentially reverse some of the detrimental effects of the PMP22 duplication. By modulating lipid metabolism and restoring plasma membrane organization, novel therapeutic strategies could be developed to alleviate the symptoms of CMT1A and to improve the quality of life for affected individuals.

Prof. Ludo Van Den Bosch said, "Using patient-derived cells, our work provides a foundation for the development of targeted therapies that address the underlying molecular defects in CMT1A. By understanding how PMP22 duplication disrupts lipid homeostasis, we can now explore innovative approaches to restore cellular function and potentially halt the progression of this devastating disease."

As researchers continue to explore the complexities of genetic disorders like CMT1A, new opportunities emerge for the development of therapies that target the root causes of disease. In this case, the effect of a on developing Schwann cells points the way ahead to future therapeutic interventions.

More information: Robert Prior et al, PMP22 duplication dysregulates lipid homeostasis and plasma membrane organization in developing human Schwann cells, Brain (2024). DOI: 10.1093/brain/awae158

Journal information: Brain
Citation: The importance of a disturbed lipid metabolism in Charcot-Marie-Tooth disease (2024, June 3) retrieved 25 July 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Genome-editing technique shows promise as treatment for common hereditary nerve disease


Feedback to editors